balance equationinconsistent2024-09-30
Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.
Revenue
$4.02M
Fiscal year ended 2025-12-31Operating income
$340.71K
Fiscal year ended 2025-12-31Free cash flow
-$621.21K
Fiscal year ended 2025-12-31Valuation, from the filing
| Public float | $4.27M | Market value of stock held by non-affiliates, as stated on the cover page for 2024-06-28 |
|---|---|---|
| Float per share | $0.01 | Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself. |
| Float / revenue | 1.5× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / equity | 0.1× | A lower bound on the multiple, because affiliate holdings are excluded. |
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2024-06-28, not today, and each multiple below it uses the figures for the fiscal year ending 2024-12-31 — the year that filing covered.
How this compares in its industry
Percentile among the Electromedical & Electrotherapeutic Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.
| Measure | Reported | Percentile | |
|---|---|---|---|
| CapEx / revenue | 140.3% | 100th | |
| FCF margin | -396.2% | 0th | |
| Gross margin | 6.3% | 4th | |
| Current ratio | 1.21x | 13th | |
| Revenue YoY growth | 7.1% | 36th | |
| Operating margin | -13.4% | 61th |
Hongchang International Co., Ltd (HCIL) reported revenue of $4.02M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Hongchang International Co., Ltd’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Electromedical & Electrotherapeutic Apparatus.
Income
| Metric | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.02M | $3.47M | $3.84M | $46.39K | Unavailable | Unavailable | $18.20K | $2.60M | $51.40K | $6.31K |
| Cost of revenue | $3.30M | $2.86M | $3.23M | $15.66K | Unavailable | Unavailable | $18.48K | $2.50M | $62.96K | Unavailable |
| Gross profit | $718.84K | $607.14K | $613.71K | $30.74K | Unavailable | Unavailable | -$273 | $95.58K | -$11.56K | Unavailable |
| Operating income | $340.71K | $252.19K | $537.44K | -$206.66K | Unavailable | Unavailable | -$102.31K | -$61.77K | -$148.75K | -$149.31K |
| Net income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | -$96.57K | $13.64K | -$144.49K | -$138.38K |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 518.83M | shares 518.83M | shares 518.83M | shares 518.83M | Unavailable | Unavailable | shares 518.83M | Unavailable | shares 450.00M | shares 415.58M |
| Pretax income | $327.48K | $241.06K | $529.75K | -$320.12K | Unavailable | Unavailable | -$102.00K | -$56.09K | -$140.67K | -$138.38K |
| Income tax expense | $23.21K | $42.82K | $29.81K | -$10.72K | Unavailable | Unavailable | -$5.43K | -$69.73K | $3.83K | Unavailable |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $-0.00 | Unavailable | Unavailable | $0.00 | Unavailable | $0.00 | $0.00 |
| Selling, general & administrative | $378.13K | $354.95K | Unavailable | $234.53K | Unavailable | Unavailable | $102.04K | Unavailable | Unavailable | Unavailable |
| General & administrative | $376.88K | $352.34K | $76.28K | $234.56K | Unavailable | Unavailable | $102.00K | $157.32K | $137.19K | $146.30K |
| Selling & marketing | $1.26K | $2.60K | Unavailable | -$29 | Unavailable | Unavailable | $36 | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $551.78K | $32.48K | $50.04K | Unavailable | Unavailable | Unavailable | Unavailable | $895.73K | $863.12K | Unavailable |
| Total assets | $65.88M | $61.74M | $58.94M | $57.45M | Unavailable | Unavailable | $53.45M | $50.22M | $47.28M | $223.64K |
| Current assets | $8.18M | $5.41M | $3.30M | $8.13M | Unavailable | Unavailable | $2.03M | $3.96M | $2.79M | $32.45K |
| Total liabilities | $22.18M | $19.14M | $16.82M | $18.68M | Unavailable | Unavailable | $13.87M | $9.73M | $8.02M | $2.47M |
| Current liabilities | $9.68M | $6.80M | $4.79M | $6.69M | Unavailable | Unavailable | $347.32K | $1.06M | $8.02M | $2.37M |
| Total equity incl. NCI | $43.70M | $42.60M | $42.12M | $38.77M | Unavailable | Unavailable | $39.58M | $40.49M | $39.26M | $40.60M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $49.54K | $39.43K | $29.36K | Unavailable | Unavailable | Unavailable | $164 | $13.71K | $25.45K | $367 |
| Accounts receivable | $5.85M | $3.54M | $1.39M | $52.51K | Unavailable | Unavailable | $4.38K | $742.85K | $14 | Unavailable |
| Goodwill | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt | $6.87M | $6.80M | $6.52M | $6.56M | Unavailable | Unavailable | $5.95M | Unavailable | Unavailable | Unavailable |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $38.52K | $15.51K |
Cash flow
| Metric | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$315.96K | -$95.51K | -$229.83K | $2.26M | Unavailable | Unavailable | $9.72K | -$26.62K | -$145.35K | $1.87M |
| Capital expenditures | $305.24K | $416.10K | $135.59K | $86.72K | Unavailable | Unavailable | Unavailable | $204.50K | -$235.59K | Unavailable |
| Investing cash flow | -$305.24K | -$416.10K | -$135.59K | -$659.11K | Unavailable | Unavailable | -$5.05M | -$272.30K | $250.50K | $435.25K |
| Financing cash flow | $1.13M | $494.74K | -$79.88K | -$1.69M | Unavailable | Unavailable | $5.05M | $568.34K | $495.96K | -$865.44K |
| Net change in cash | $523.28K | -$16.09K | -$440.36K | -$66.45K | Unavailable | Unavailable | -$656 | $32.61K | -$11.03K | $868.93K |
| Stock-based compensation | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $204.84K | $190.92K | $188.69K | $23.25K | Unavailable | Unavailable | $22.06K | $28.57K | $22.23K | Unavailable |
Derived
| Metric | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | -$621.21K | -$511.61K | -$365.41K | $2.17M | Unavailable | Unavailable | Unavailable | -$231.12K | Unavailable | Unavailable |
| Gross margin | 17.9% | 17.5% | 16.0% | 66.3% | Unavailable | Unavailable | -1.5% | 3.7% | -22.5% | Unavailable |
| Operating margin | 8.5% | 7.3% | 14.0% | -445.5% | Unavailable | Unavailable | -562.0% | -2.4% | -289.4% | Unavailable |
| FCF margin | -15.5% | -14.7% | -9.5% | 4683.2% | Unavailable | Unavailable | Unavailable | -8.9% | Unavailable | Unavailable |
| SBC / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current ratio | 0.85x | 0.80x | 0.69x | 1.21x | Unavailable | Unavailable | 5.86x | 3.75x | 0.35x | 0.01x |
| Revenue YoY growth | 8560.2% | Unavailable | Unavailable | -98.2% | Unavailable | Unavailable | -32.9% | 5096.7% | Unavailable | -56.1% |
| Net margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | -530.5% | Unavailable | -281.1% | Unavailable |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 7.6% | 12.0% | 3.5% | 186.9% | Unavailable | Unavailable | Unavailable | 7.9% | -458.4% | Unavailable |
| Long-term debt / equity | 0.16x | 0.16x | 0.15x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 7.1% | 17.8% | 5.6% | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HCIL in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-02-13View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-K · Filed 2025-03-28View SEC filing
10-Q · Filed 2024-11-13View SEC filing
10-Q · Filed 2024-08-13View SEC filing
Reconciliation checks needing review
9 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
gross profit bridgeinconsistent2024-09-30
Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.
balance equationinconsistent2024-06-30
Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.
gross profit bridgeinconsistent2024-06-30
Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.
gross profit bridgeinconsistent2023-06-30
Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.
balance equationreview2023-06-30
Difference 42847423 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2023-03-31
Difference 44840073 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2022-09-30
Difference 1492320 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2021-12-31
Difference 1616096 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.